PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Vitamin D–fortified yoghurt improves cholesterol levels and heart disease biomarkers for diabetics

2011-11-24
(Press-News.org) People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.

Not having enough vitamin D affects the inner lining of blood vessels (endothelial cells) eventually leading to atherosclerosis and cardiovascular disease. Endothelial dysfunction can be measured by the increased levels of a set of biomarkers, such as serum endothelin-1, E-Selectin and MMP-9. In a double-blind trial, researchers from Tehran investigated the effect of vitamin D on the glycemic status, cholesterol levels and endothelial biomarkers of diabetics. Patients were given either a plain yoghurt drink (Doogh) or the same drink fortified with vitamin D twice a day for 12 weeks.

Researchers from the National Research Institute and Faculty of Nutrition and Food Technology had previously shown that a vitamin D-fortified yoghurt drink could improve the glycemic status of people with type 2 diabetes. In collaboration with Tehran University of Medical Sciences their new trial showed that vitamin D improved the fasting glucose, insulin, QUICK1 (a measure of insulin resistance), and found some improvement in long term HbA1c.

Dr Neyestani explained, "The patients who had taken the vitamin D yoghurt also had improved cholesterol levels with lower total cholesterol and LDL levels and an increase in HDL. All the improvements in cholesterol seemed to be due to the reduction in insulin resistance. The biomarkers of endothelial dysfunction, serum endothelin-1, E-Selectin and MMP-9, levels were also lower for the patients taking vitamin D."

Prof Djazayery continued, "Most of our patients were deficient in vitamin D at the start of the trial but the fortified yoghurt drink elevated most of their levels to normal. However, even amongst those who took the vitamin D supplement, some people (about 5%) remained deficient at the end of the 12 weeks. These people did not show the same improvements. Nevertheless for most diabetics with vitamin D deficiency this is an easy way to improve their outcome."

### Media Contact
Dr Hilary Glover
Scientific Press Officer, BioMed Central
Tel: 44-20-3192-2370
Email: hilary.glover@biomedcentral.com

Notes to Editors

1. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: A randomized double-blind clinical trial Sakineh Shab-Bidar, Tirang R Neyestani, Abolghassem Djazayery, Mohammad-Reza Eshraghian, Anahita Houshiarrad, A'azam Gharavi, Ali Kalayi, Nastaran Shariatzadeh, Malihe Zahedirad, Niloufar Khalaji and Homa Haidari BMC Medicine (in press)

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication.

2. BMC Medicine - the flagship medical journal of the BMC series - publishes original research articles, commentaries and reviews in all areas of medical science and clinical practice. To be appropriate for BMC Medicine, articles need to be of outstanding quality, broad interest and special importance. BMC Medicine (ISSN 1741-7015) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, CAS, EMBASE, Scopus, Current Contents, Thomson Reuters (ISI) and Google Scholar.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.


ELSE PRESS RELEASES FROM THIS DATE:

Dreaming takes the sting out of painful memories

2011-11-24
They say time heals all wounds, and new research from the University of California, Berkeley, indicates that time spent in dream sleep can help. UC Berkeley researchers have found that during the dream phase of sleep, also known as REM sleep, our stress chemistry shuts down and the brain processes emotional experiences and takes the painful edge off difficult memories. The findings offer a compelling explanation for why people with post-traumatic stress disorder (PTSD), such as war veterans, have a hard time recovering from painful experiences and suffer reoccurring ...

Employment Agreements: When to Use Non-Competition and Non-Solicitation Clauses

2011-11-24
In today's marketplace, employees change jobs frequently as certain skill sets are in high demand. Many Utah businesses do not adequately protect themselves for the potential departures of these special high performing employees. Recently, Ford Motor Company filed suit against a past marketing executive who, after leaving Ford, took a job as President of a large Toyota distributor. Ford's concerns included the possibility of its former employee taking valuable business knowledge and giving that to a direct competitor. The former Ford employee had signed a non-compete ...

Simple night time airflow control device eases persistent asthma symptoms

2011-11-24
A simple device that filters out airborne asthma triggers during sleep can ease persistent symptoms of the condition during the day and improve quality of life, suggests research published online in Thorax. Temperature controlled laminar airflow treatment, or TLA for short, delivers a constant, slightly cooled airflow in the patient's breathing area, which displaces warmer air containing irritants and allergens, such as house dust mite and pet hairs. The aim is to stave off the abnormal immune response that triggers a systemic allergic reaction, including the airway ...

Doctors could learn from Shakespeare’s deep understanding of mind-body connection

2011-11-24
Shakespeare was a master at portraying profound emotional upset in the physical symptoms of his characters, and many modern day doctors would do well to study the Bard to better understand the mind-body connection, concludes an analysis of his works, published in Medical Humanities. Kenneth Heaton, a medical doctor and extensively published author on William Shakespeare's oeuvre, systematically analysed 42 of the author's major works and 46 of those of his contemporaries, looking for evidence of psychosomatic symptoms. He focused on sensory symptoms other than those ...

Firefighters more likely to be injured exercising than putting out fires

2011-11-24
Firefighters are more likely to be injured while exercising than while putting out fires, suggests research published online in Injury Prevention. But carrying patients is the task most likely to require time off work, the study shows. Combined firefighting and emergency medical services have one of the highest workplace injury and death rates in the US. The authors looked at data for injuries sustained while at work for 21 fire stations serving the metropolitan area of Tucson, Arizona between 2004 and 2009. The 650 employees included firefighters, paramedics, ...

Law Enforcement Officials Turning to Facebook as a Crime Fighting Tool

2011-11-24
Increased participation on social networking sites has resulted in law enforcement officers in New York and across the nation to turn to sites such as Facebook for information and evidence. Officers can use information found on individual users' pages to track their location, view photos and other personal information shared on their profiles. And it is not just information made public by the users' privacy settings. Facebook's privacy agreement allows Facebook to share information posted on the website with law enforcement officials if there is a good faith belief that ...

Researchers develop method for advancing development of antipsychotic drugs

2011-11-24
RICHMOND, Va. (Nov. 23, 2011) – Researchers interested in the treatment of schizophrenia and dementia have clarified how antipsychotic drugs that target a complex of two receptors at the surface of cells in the brain work, according to a new study published online Nov. 23 in the journal Cell. The multidisciplinary team included researchers from the Virginia Commonwealth University School of Medicine, together with the Mount Sinai School of Medicine in New York and the University of Maryland School of Pharmacy in Baltimore. In an earlier, but related study, the Mount Sinai ...

Mite-y genomic resources for bioenergy crop protection

2011-11-24
WALNUT CREEK, Calif. -- For a pest that isn't quite the size of a comma on a keyboard, the two-spotted spider mite can do a disproportionate amount of damage. These web-spinners extract the nutrients they need from leaves of more than a thousand different plant species, including bioenergy feedstocks and food staples. The cost of chemically controlling spider mites to counteract reduced harvest yields hovers around $1 billion annually, reflecting their significant economic impact. With a 90-million nucleotide genome, the smallest of those that belong to the group of animals ...

Caltech scientists point to link between missing synapse protein and abnormal behaviors

Caltech scientists point to link between missing synapse protein and abnormal behaviors
2011-11-24
PASADENA, Calif. -- Although many mental illnesses are uniquely human, animals sometimes exhibit abnormal behaviors similar to those seen in humans with psychological disorders. Such behaviors are called endophenotypes. Now, researchers at the California Institute of Technology (Caltech) have found that mice lacking a gene that encodes a particular protein found in the synapses of the brain display a number of endophenotypes associated with schizophrenia and autism spectrum disorders. The new findings appear in a recent issue of the Journal of Neuroscience, with Mary ...

Scientific sleuths pinpoint the guilty coral killers

2011-11-24
The elusive culprits that are killing countless coral reefs around the world can now be nabbed with technology normally used to diagnose human diseases, marine researchers say. Coral researchers and reef managers will be able to identify coral infections using a new method that allows them to classify specific diseases based on the presence of microbes. This could lead to more effective action to reduce the impact of disease on the world's imperilled coral reefs. "Current classification of coral diseases is mostly based on a description of how the coral has deteriorated, ...

LAST 30 PRESS RELEASES:

Dr. Gianluca Ianiro wins a prestigious grant from the European Research Council (ERC)

‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth

Clinical study deepens understanding of mesothelioma and opens the door to potential treatment options

New study and major data updates expand the Kids First data ecosystem

Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

[Press-News.org] Vitamin D–fortified yoghurt improves cholesterol levels and heart disease biomarkers for diabetics